"LinXis soon to move into the Amsterdam UMC Imaging Center"

Read more

About LinXis

We are a Dutch biotechnology company on a mission to provide better and safer treatments for patients suffering from life-threatening disease.

Our proprietary platform technology enables us to construct smart medicines, by attaching extremely effective drugs to extremely specific carriers, such as antibodies or antibody fragments (also known as nanobodies). These smart medicines, known as antibody-drug conjugates or nanobody-drug conjugates, are designed to carry the drugs to the diseased cells with military precision, and without collateral damage. The ultimate goal of these conjugates is to cure disease without side effects.

We are not the first to create such conjugates. But our technology is markedly different from any other technology in the field, because we use platinum to attach the drugs to the carriers. This approach results in conjugates that are remarkably effective and safe. Moreover, the simplicity of this approach will enable us to produce these high-tech medicines at a considerably lower cost.